Fatigue-Busting combo for cancer patients shows promise in new study
NCT ID NCT03525873
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 25 times
Summary
This study looks at whether a medication called methylphenidate (often used for ADHD) combined with physical activity can reduce severe tiredness in people with advanced cancer who are on immunotherapy. About 212 participants will be randomly assigned to receive either the drug or a placebo, plus an exercise program. The goal is to improve energy and quality of life during treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.